DK0566666T3 - Nye glucohydrolase-inhibitorer anvendelige som antidiabetiske, antivirale og antimetastatiske midler - Google Patents

Nye glucohydrolase-inhibitorer anvendelige som antidiabetiske, antivirale og antimetastatiske midler

Info

Publication number
DK0566666T3
DK0566666T3 DK92904197T DK92904197T DK0566666T3 DK 0566666 T3 DK0566666 T3 DK 0566666T3 DK 92904197 T DK92904197 T DK 92904197T DK 92904197 T DK92904197 T DK 92904197T DK 0566666 T3 DK0566666 T3 DK 0566666T3
Authority
DK
Denmark
Prior art keywords
antidiabetic
antiviral
new
inhibitors useful
pct
Prior art date
Application number
DK92904197T
Other languages
English (en)
Inventor
Robert A Farr
Norton P Peet
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0566666T3 publication Critical patent/DK0566666T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08Six-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/567Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with sulfur as the only hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/20Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)
DK92904197T 1991-01-10 1991-12-13 Nye glucohydrolase-inhibitorer anvendelige som antidiabetiske, antivirale og antimetastatiske midler DK0566666T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63963591A 1991-01-10 1991-01-10
US78420891A 1991-10-28 1991-10-28
PCT/US1991/009387 WO1992011867A1 (en) 1991-01-10 1991-12-13 Novel glucohydrolase inhibitors useful as antidiabetic agents

Publications (1)

Publication Number Publication Date
DK0566666T3 true DK0566666T3 (da) 1999-12-06

Family

ID=27093368

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92904197T DK0566666T3 (da) 1991-01-10 1991-12-13 Nye glucohydrolase-inhibitorer anvendelige som antidiabetiske, antivirale og antimetastatiske midler

Country Status (15)

Country Link
US (1) US5438069A (da)
EP (1) EP0566666B1 (da)
JP (1) JP2951723B2 (da)
KR (1) KR100192862B1 (da)
AT (1) ATE183100T1 (da)
AU (1) AU660641B2 (da)
CA (1) CA2098927A1 (da)
DE (1) DE69131522T2 (da)
DK (1) DK0566666T3 (da)
ES (1) ES2136615T3 (da)
GR (1) GR3031423T3 (da)
IE (1) IE920087A1 (da)
NZ (1) NZ241234A (da)
PT (1) PT100001B (da)
WO (1) WO1992011867A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE126696T1 (de) * 1985-12-23 1995-09-15 Hutchinson Fred Cancer Res Regulierung der retroviralen replikation, infektion und pathogenese.
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
CA2267412A1 (en) * 1996-10-01 1998-04-09 Glycodesign Inc. Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
CA2286766A1 (en) 1997-04-15 1998-10-22 Glycodesign Inc. Alkaloid halide salts of swainsonine and methods of use
US5998485A (en) * 1997-06-16 1999-12-07 Cedars-Sinai Medical Center Method for modulating immune response with inositol
CA2307595A1 (en) * 1997-10-24 1999-05-06 Glycodesign Inc. Synthesis of swainsonine salts

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4205068A (en) * 1978-05-18 1980-05-27 E. R. Squibb & Sons, Inc. β-Lactamase inhibitor EM4615
EP0056194B1 (en) * 1981-01-05 1984-09-12 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars, their production and use
US4399224A (en) * 1981-07-13 1983-08-16 A. E. Staley Manufacturing Company Enzymatically treated phosphatides
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
DE3372774D1 (en) * 1982-09-16 1987-09-03 Wako Pure Chem Ind Ltd Modified oligosaccharides used as substrate for measuring alpha-amylase activity
ES2058070T3 (es) * 1986-05-09 1994-11-01 Pulverer Gerhard Utilizacion de monosacaridos especificos para la preparacion de un medicamento para impedir metastasis de tumores malignos.
US4963479A (en) * 1986-10-07 1990-10-16 Hoechst Celanese Corporation Reagent system for an alpha-amylase assay containing aromatic substituted glycoside
US4962097A (en) * 1988-10-28 1990-10-09 Merck & Co., Inc. Method of treating bacterial infection with phosphorus containing DHP enzyme inhibitors
US5032505A (en) * 1988-11-21 1991-07-16 Chembiomed, Ltd. Inhibitors for glycosaminosyl transferase V
US4988682A (en) * 1989-02-03 1991-01-29 University Of Pittsburgh Myo-inositol analogs and method for their use
US5053399A (en) * 1989-02-03 1991-10-01 University Of Pittsburgh Myo-inositol analogs and methods for their use
US5240707A (en) * 1990-04-12 1993-08-31 Merrell Dow Pharma Alpha-mannosidase and fucosidase inhibitors

Also Published As

Publication number Publication date
AU660641B2 (en) 1995-07-06
PT100001A (pt) 1993-02-26
DE69131522D1 (de) 1999-09-16
DE69131522T2 (de) 1999-11-25
KR930703013A (ko) 1993-11-29
AU9176091A (en) 1992-08-17
JP2951723B2 (ja) 1999-09-20
NZ241234A (en) 1994-07-26
JPH06504550A (ja) 1994-05-26
EP0566666A1 (en) 1993-10-27
PT100001B (pt) 1999-06-30
ATE183100T1 (de) 1999-08-15
GR3031423T3 (en) 2000-01-31
IE920087A1 (en) 1992-07-15
ES2136615T3 (es) 1999-12-01
EP0566666A4 (en) 1994-06-08
US5438069A (en) 1995-08-01
WO1992011867A1 (en) 1992-07-23
KR100192862B1 (ko) 1999-06-15
EP0566666B1 (en) 1999-08-11
CA2098927A1 (en) 1992-07-11

Similar Documents

Publication Publication Date Title
DK0724435T3 (da) Amidinoderivater, der er nyttige som nitrogenoxid-synthase-inhibitorer
TW349843B (en) Substituted 1-arylpyrazoles
DE69115280D1 (de) Indolderivate, die die leukotrienbiosynthese hemmen.
GT199900150A (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas.
NO975716L (no) Imidazolforbindelser
TR199800077T1 (xx) Kontroll� ��z�len paroksetin terkipleri.
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
SE9604793D0 (sv) New polymorphs
DK0937074T3 (da) Benzonaphthyridiner som bronkiale terapeutiske midler
DK0941221T3 (da) Substituerede dihydrobenzofuraner som PDE-inhibitorer
PT920426E (pt) Novos derivados de tiazole com efeito inibidor de fosfodiesterase
ES2131528T3 (es) Nuevos polipeptidos y su uso.
FI973221A (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
DK0623121T3 (da) Fremstilling af N-acetylneuraminsyrederivater
DK0566666T3 (da) Nye glucohydrolase-inhibitorer anvendelige som antidiabetiske, antivirale og antimetastatiske midler
DK0588796T3 (da) Sampanginderivater til anvendelse som antifungiske og antimykobakterielle midler
FR2707990B1 (fr) Nouvelles nitrones utilisables pour le piégeage des radicaux libres.
PT100891A (pt) Per-hidro-1h-pirido {1,2-a} pirazinas 2-substituidas neurolepticas
ES2147282T3 (es) Utilizacion de al menos un carburo terpenico y/o uno de sus derivados como adyuvante de un caldo herbicida o coformulante de una composicion herbicida
DK0641346T3 (da) Antibiotiske 7-aminonaphthazarinderivater
FI962301A0 (fi) Substituoidut aminoalkyyliaminopyridiinit
ES2074250T3 (es) Azocolorantes, procedimiento para su preparacion y su empleo.
DE69717147T2 (de) Thrombin inhibitoren
DK0659184T3 (da) Optisk aktivt hydroquinin-1-(3-aminophenyl)-ethansulfonat samt fremstilling og anvendelse deraf
ECSP972052A (es) Quinoxalinadionas